Evidence map›Paper›PMID 28070237›Full record

ArticleWorld journal of cardiology2016

To ventricular assist devices or not: When is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure?

Emily Cerier, Brent C Lampert, Arman Kilic, Asia McDavid, Salil V Deo, Ahmet Kilic

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Left Ventricular Assist Device in the Management of Heart Failure: A Single-Center Experience.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily CerierEmily Cerier, Asia McDavid, Ahmet Kilic, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Brent C LampertEmily Cerier, Asia McDavid, Ahmet Kilic, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Arman KilicEmily Cerier, Asia McDavid, Ahmet Kilic, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Asia McDavidEmily Cerier, Asia McDavid, Ahmet Kilic, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Salil V DeoEmily Cerier, Asia McDavid, Ahmet Kilic, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
Ahmet KilicEmily Cerier, Asia McDavid, Ahmet Kilic, Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced heart failure has been traditionally treated via either heart transplantation, continuous inotropes, consideration for hospice and more recently via left ventricular assist devices (LVAD). Heart transplantation has been limited by organ availability and the futility of other options has thrust LVAD therapy into the mainstream of therapy for end stage heart failure. Improvements in technology and survival combined with improvements in the quality of life have made LVADs a viable option for many patients suffering from heart failure. The question of when to implant these devices in those patients with advanced, yet still ambulatory heart failure remains a controversial topic. We discuss the current state of LVAD therapy and the risk vs benefit of these devices in the treatment of heart failure.

Indexed as

CardiomyopathyDiastolic dysfunctionHeart failureLeft ventricular assist deviceMechanical circulatory support

Identifiers

PMID28070237
PMCPMC5183969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.